0001237899-13-000022.txt : 20130416
0001237899-13-000022.hdr.sgml : 20130416
20130416123929
ACCESSION NUMBER: 0001237899-13-000022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130411
FILED AS OF DATE: 20130416
DATE AS OF CHANGE: 20130416
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER RD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591-6707
BUSINESS PHONE: 9143477000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McCorkle Douglas S
CENTRAL INDEX KEY: 0001403178
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 13763227
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2013-04-11
0
0000872589
REGENERON PHARMACEUTICALS INC
REGN
0001403178
McCorkle Douglas S
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
VP Controller and Asst Treasur
Common Stock
2013-04-11
4
M
0
5875.0
30.63
A
9875
D
Common Stock
2013-04-11
4
F
0
879.0
204.57
D
8996
D
Common Stock
2013-04-11
4
F
0
1867.0
204.57
D
7129
D
Common Stock
2013-04-12
4
S
0
100.0
205.82
D
7029
D
Common Stock
2013-04-12
4
S
0
100.0
207.32
D
6929
D
Common Stock
2013-04-12
4
S
0
200.0
208.25
D
6729
D
Common Stock
2013-04-12
4
S
0
482.0
209.48
D
6247
D
Common Stock
2013-04-12
4
S
0
600.0
210.65
D
5647
D
Common Stock
2013-04-12
4
S
0
731.0
211.47
D
4916
D
Common Stock
2013-04-12
4
S
0
318.0
212.54
D
4598
D
Common Stock
2013-04-12
4
S
0
298.0
213.12
D
4300
D
Common Stock
2013-04-12
4
S
0
300.0
214.1
D
4000
D
Common Stock
4066
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
30.63
2013-04-11
4
M
0
5875.0
D
2020-12-14
Common Stock
5875
8430
D
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
Represents volume-weighted average price of sales of 200 shares of Company stock on April 12, 2013 at prices ranging from $208.10 to $208.39. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price.
Represents volume-weighted average price of sales of 482 shares of Company stock on April 12, 2013 at prices ranging from $209.12 to $209.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price.
Represents volume-weighted average price of sales of 600 shares of Company stock on April 12, 2013 at prices ranging from $210.13 to $210.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price.
Represents volume-weighted average price of sales of 731 shares of Company stock on April 12, 2013 at prices ranging from $211.00 to $211.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price.
Represents volume-weighted average price of sales of 318 shares of Company stock on April 12, 2013 at prices ranging from $212.30 to $212.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price.
Represents volume-weighted average price of sales of 298 shares of Company stock on April 12, 2013 at prices ranging from $213.00 to $213.19. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price.
Represents volume-weighted average price of sales of 300 shares of Company stock on April 12, 2013 at prices ranging from $214.00 to $214.25. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 12, 2013 at each separate price.
The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
/s/**Douglas M. McCorkle
2013-04-16